Receptos Shares Down 2.4% After Earnings Miss (RCPT)
Receptos (NASDAQ:RCPT) dropped 2.4% during trading on Wednesday following a dissappointing earnings announcement, Analyst Ratings Network reports. The stock traded as low as $41.98 and last traded at $42.95, with a volume of 396,988 shares traded. The stock had previously closed at $44.02.
The company reported ($1.04) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.85) by $0.19. The company had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.28 million.
A number of analysts have recently weighed in on RCPT shares. Analysts at Leerink Swann initiated coverage on shares of Receptos in a research note on Wednesday. They set an “outperform” rating and a $60.00 price target on the stock. Separately, analysts at Nomura initiated coverage on shares of Receptos in a research note on Monday, June 30th. They set a “buy” rating and a $63.00 price target on the stock. Finally, analysts at BMO Capital Markets set a $58.00 price target on shares of Receptos in a research note on Tuesday, June 10th. Three research analysts have rated the stock with a buy rating, Receptos currently has a consensus rating of “Buy” and an average target price of $55.00.
The stock’s 50-day moving average is $40.05 and its 200-day moving average is $39.12. The company’s market cap is $989.2 million.
Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.